Neurofibromatosis (NF) Registry Portal

Neurofibromatosis 1 Clinical Trial

Official title:

Neurofibromatosis (NF) Registry Portal Funded by Children's Tumor Foundation

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT01885767
• Other study ID #: CTF001
• Status: Recruiting
• Start date: June 2012
• Est. completion date: June 2050

Study information

• Verified date: August 2023
• Source: The Children's Tumor Foundation
• Contact: Kate Kelts, B.S.N.
• Phone: 646-738-8567
• Email: kkelts[@]ctf.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The NF Registry is a database of patient-reported symptoms, treatments, and experiences with their neurofibromatosis disease. It is a contact registry to relay clinical trial opportunities to targeted patient subgroups, and to supply de-identified disease data to researchers. It has the potential to become a natural history resource.

Description:

Patients and parents of patients will be made aware of the Neurofibromatosis (NF) Registry through various non-commercial information sources such as the Children's Tumor Foundation (CTF) website, CTF-affiliated NF clinics, social media, CTF educational and fundraising events, and other nonprofit organizations and foundations such as the National Organization for Rare Diseases (NORD) and social media.

The NF Registry will be accessed by individual adult (over age 18) subjects via a web-based patient portal. The portal contains an IRB-approved informed consent form. Following consent, the registrant creates an account which is activated after email confirmation. An account can be created by an adult patient with the disorder, or by the parent or guardian of a child with the disorder. Account creators are required to enter identifiable contact and demographic data.

After the account is created, the account owner enrolls themselves or a minor family member (or both) and completes an on-line survey. There are separate surveys for NF1, NF2, and Schwannomatosis. The surveys ask about about the affected individual's medical and family history of the disease, testing and diagnosis, clinical manifestations (e.g., tumor types and locations) interventions and therapies, and quality of life. The account holder chooses whether to receive emails from the Registry with information about relevant clinical trials and studies for which they may be eligible.

Participant's responses are used to compile charts and graphics of de-identified aggregate data. Registered patients may view this data. Researchers may apply to our Data Use Committee for access to de-identified data or for subject recruitment emails to be sent to specific patient subgroups. Data capture and security for the NF Registry is done under contract by OpenApp (Dublin, Ireland), a web-based patient opt-in registry provider.Participants will be asked to update their information at least once a year. Their information will be stored in the NF Registry for an indefinite period of time. This longitudinal study is intended as a resource for patients and researchers. There is no specific outcome measure or anticipated endpoint.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 20000
• Est. completion date: June 2050
• Est. primary completion date: June 2030
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosed with NF1

• Diagnosed with NF2

• Diagnosed with Schwannomatosis

Exclusion Criteria:

• Failure to complete account registration

Related Conditions & MeSH terms

• Neurofibroma
• Neurofibromatoses
• Neurofibromatosis 1
• Neurofibromatosis 2
• Schwannomatosis

Locations

Country	Name	City	State
United States	Children's Tumor Fundation	New York	New York

Sponsors (1)

Lead Sponsor	Collaborator
The Children's Tumor Foundation

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	To create a natural history of NF1, NF2, and schwannomatosis	patients will input medical information and treatment information about their NF and update at least yearly in an ongoing natural history study	final report in 2050 with descriptive statistics

External Links

•   NF Registry